Related Topics
Failure of tuberculosis treatment linked to bacterial resilience
Researchers have discovered a new form of altered drug susceptibility—dubbed antibiotic resilience—that enables Mycobacterium tuberculosis to survive antibiotic treatment.
Confronting the challenges of long COVID
At a September 23 virtual event at Harvard Chan School, experts discussed the wide-ranging impacts of long COVID and current research strategies for advancing treatments and diagnosis.
Science unclear around fourth COVID-19 shot
Several countries have authorized second booster shots of COVID-19 vaccine, but concerns have recently been raised about whether this is a useful approach.
Flaminia Catteruccia named Howard Hughes Medical Institute investigator
For immediate release: Thursday, September 23, 2021 Boston, MA ─ The Howard Hughes Medical Institute (HHMI) has named Flaminia Catteruccia, professor of immunology and infectious diseases at Harvard T.H. Chan School of Public Health, as one of 33 new…
Leading coronavirus scientist, Kizzmekia S. Corbett, to join Harvard T.H. Chan School of Public Health to continue vaccine development research
Leading coronavirus scientist Kizzmekia S. Corbett is joining Harvard Chan School as an assistant professor to continue vaccine development research.
Op-ed: Preventing disease by addressing climate change, understanding immunity
To reduce the threat of major global diseases such as COVID-19, governments must make greater investments in climate-change solutions and in understanding how the human immune system works, says Wayne Koff, adjunct professor of epidemiology at Harvard T.H.…
Exploring how ‘forever chemicals’ may harm immune function
Mounting evidence suggests that widely used chemicals called per- and polyfluoroalkyl substances (PFASs) interfere with immune system function. Experts are concerned that exposure to these chemicals could diminish the immune system’s ability to fight a host of infectious…
A Shot in the Arm
Vaccines are underfunded, understudied, and underappreciated as a vital tool in public health. could COVID-19 be the start of a vaccine renaissance?
We're better off with mRNA vaccines
The technology that is helping us combat COVID-19 is also poised to help us tackle tough infectious and non-infectious diseases. Immunologist Sarah Fortune explains how these vaccines work, and how the mRNA platform could transform the prevention and…
Ensuring safe and effective COVID-19 vaccines for vulnerable populations
Although COVID-19 vaccines have begun reaching people around the world, challenges remain to ensuring that the vaccines help those who are most vulnerable, according to an article co-authored by experts from Harvard T.H. Chan School of Public Health.
